Press Releases :: Soliton, Inc. (SOLY)

Lead Investigator Evaluates Next-Step for Soliton Pivotal Cellulite Clinical Data

Mar 20, 2020

Soliton Receives FDA Clearance of Special 510(k)

Mar 11, 2020

Soliton signs Agreement with Global Manufacturer Sanmina

Mar 9, 2020

Soliton to Present Pivotal Cellulite Clinical Trial Results at AAD on March 21, 2020

Mar 3, 2020

Soliton Reports Fourth Quarter and Full Year 2019 Results

Mar 2, 2020

Soliton Files Special 510(k) with FDA for its Generation II RAP Device

Feb 11, 2020

Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales Consultant

Feb 6, 2020

Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials

Jan 27, 2020

Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

Jan 13, 2020

Soliton Appoints Robert "Joe" Mills as Vice President of Supply Chain

Jan 7, 2020

First Name*
First
Email*
Cell (Optional: Used For Press Releases)

© 2020 Soliton Inc. All Rights Reserved, Soliton Inc.